Skip to main content
logo
Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
29.08
+0.04 (0.14%)
At close: Jan 5, 2026

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Antibody-drug Conjugates
40.50M
Log In
Log In
Log In
Log In
Upgrade
Antibody-drug Conjugates Growth
9.88%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
40.50M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.88%
Log In
Log In
Log In
Log In
Upgrade